ADVERTISEMENT
ADVERTISEMENT
Ravi Thadani takes on Cedars-Sinai leadership role
His appointment is effective Sept. 1.
-
Bhavana P - Fri, 24, Jul 2026
- 16:57 EDT
- 50
Ravi Thadani / Cedars-Sinai
Cedars-Sinai Medical Center has appointed Indian-American physician Ravi Thadhani as its inaugural executive vice president, chief physician executive and dean of the medical faculty.
In the newly created leadership role, Thadhani will oversee Cedars-Sinai's academic and clinical enterprises, bringing together the organization's patient care, research and education missions. He will lead department chairs, institute directors, executive vice deans, vice deans and chief medical officers across the health system.
Thadhani succeeds Shlomo Melmed, who served as dean of the medical faculty and executive vice president of Medicine and Health Sciences for 28 years. Melmed will transition to the roles of dean emeritus of the Medical Faculty and executive adviser to Cedars-Sinai president and CEO Peter L. Slavin.
Also read: Mews appoints Kirupa Pushparaj as chief legal officer
Most recently, Thadhani served as executive vice president of clinical affairs and chief medical officer for Cedars-Sinai Medical Center and Cedars-Sinai Health System. In his expanded role, he will continue overseeing clinical quality and safety, medical affairs and standards of care while assuming responsibility for all academic and education programs, including Cedars-Sinai Health Sciences University and the Burns and Allen Research Institute.
Before returning to Cedars-Sinai, Thadhani held leadership positions at Emory University, where he served as executive vice president for health affairs, executive director of the Woodruff Health Sciences Center and vice chair of the Emory Healthcare board of directors. Earlier in his career, he held faculty and leadership appointments at Harvard Medical School, Massachusetts General Hospital and Mass General Brigham.
A physician-scientist specializing in nephrology and preeclampsia, Thadhani has authored or co-authored more than 300 scientific publications. He also played a key role in developing the first U.S. Food and Drug Administration-approved test to predict preeclampsia.
Earlier this year, Thadhani was elected a Fellow of the American Association for the Advancement of Science, following his election to the National Academy of Medicine in 2025.
“I am deeply honored to step into this role at such a pivotal moment for Cedars-Sinai. I am grateful to Dr. Melmed for the extraordinary foundation he has built, and I look forward to working closely with our talented leaders and faculty to forge the next chapter of our academic and clinical mission,” Thadhani said.
Born in India, Thadhani earned his Doctor of Medicine degree from the University of Pennsylvania School of Medicine. He received a Master of Public Health degree from the Harvard T.H. Chan School of Public Health and a bachelor's degree from the University of Notre Dame.
Discover more at New India Abroad.
Leave A Comment
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login